The Food and Drug Administration (FDA) yesterday said that pharmaceutical company Sanofi Taiwan is recalling nine batches of three types of irbesartan, an antihypertensive drug, due to the presence of an impurity.
The types of irbesartan being recalled are Sanofi Taiwan’s Aprovel 150mg film-coated tablets (license No. 022551), Aprovel 300mg film-coated tablets (license No. 022843) and Coaprovel 300mg/12.5mg film-coated tablets (license No. 023267).
The nine batches being recalled are: AA191, AA204 and AA269 of the Aprovel 150mg tablets; AA642, AA645, AA658, AA659 and AA707 of the Aprovel 300mg tablets; and AA531 of the Coaprovel 300mg/12.5mg tablets, the FDA said.
While monitoring international drug safety data, the FDA noticed that some sartan medicines — angiotensin II receptor blockers — contained a chemical compound known as azidomethyl-biphenyl-tetrazole (AZBT) and requested that drugmakers self-inspect their sartan drugs for the substance.
Hung Kuo-teng (洪國登), head of the FDA’s Medicinal Products Division, said that the agency received a report from Sanofi Taiwan last month saying that AZBT was detected in its irbesartan drugs in excess of the acceptable levels listed in the ICH guideline M7.
The guideline emphasizes considerations of safety and quality risk management in establishing levels of mutagenic impurities that are expected to pose negligible carcinogenic risk, the European Medicines Agency Web site says.
Hung said that AZBT is a mutagenic azido impurity that can form during the manufacture of sartan active substances, but it is not a nitrosamine — carcinogenic to animals — and that the specific risk posed by AZBT to the human body is unclear.
The nine batches of Sanofi Taiwan’s irbesartan drugs — about 9 million tablets — are undergoing a recall until Nov. 26, and the company is required to submit a recall progress report, Hung said.
National Health Insurance data shows that nearly 40 million tablets of the three types of drugs are consumed in Taiwan each year, he said.
The FDA strongly recommends that people with high blood pressure who are taking the drugs in these batches consult with their doctor before stopping the medicine.
It also requested that healthcare facilities and pharmacies stop providing the drugs in these batches and cooperate with Sanofi Taiwan’s drug recall process.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
The Ministry of Finance this afternoon announced the winning numbers for the March-April uniform invoice lottery. The winning number for the NT$10 million (US$318,060) special prize is 19531471, and the winning number for the NT$2 million grand prize is 85941329. Three numbers were drawn for the NT$200,000 first prize: 07225810, 20231230 and 83518781. Those with receipts matching the last seven digits of any of the first-prize numbers will win the NT$40,000 second prize, while those matching the last six digits will win the NT$10,000 third prize. Those whose receipts match the last five digits of the first-prize numbers can claim the NT$4,000 fourth prize,
Former president Ma Ying-jeou (馬英九) yesterday expressed “shock and regret” over a statement issued by his wife without his consent, and rejected her assertion that his eldest sister, Ma Yi-nan (馬以南), would manage his medical care or act as his spokesperson amid an ongoing embezzlement probe into his foundation. Ma Ying-jeou in a statement said he was shocked by a statement by his wife, Chou Mei-ching (周美青), regarding his affairs. Ma Yi-nan “must not” be in charge of his healthcare and other personal affairs, nor can she be allowed to represent the Ma family, the former president said. He said he was also
RSS